- Home
- ROIV vs BLD Comparison
ROIV vs BLD Comparison
Compare ROIV & BLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- BLD
- Stock Information
- Founded
- ROIV 2014
- BLD 2015
- Country
- ROIV United Kingdom
- BLD United States
- Employees
- ROIV N/A
- BLD N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- BLD Engineering & Construction
- Sector
- ROIV Health Care
- BLD Consumer Discretionary
- Exchange
- ROIV Nasdaq
- BLD Nasdaq
- Market Cap
- ROIV 8.4B
- BLD 8.8B
- IPO Year
- ROIV N/A
- BLD N/A
- Fundamental
- Price
- ROIV $10.38
- BLD $305.57
- Analyst Decision
- ROIV Strong Buy
- BLD Buy
- Analyst Count
- ROIV 6
- BLD 9
- Target Price
- ROIV $17.10
- BLD $403.88
- AVG Volume (30 Days)
- ROIV 6.9M
- BLD 352.9K
- Earning Date
- ROIV 02-10-2025
- BLD 05-06-2025
- Dividend Yield
- ROIV N/A
- BLD N/A
- EPS Growth
- ROIV N/A
- BLD 4.97
- EPS
- ROIV N/A
- BLD 20.29
- Revenue
- ROIV $122,585,000.00
- BLD $5,329,803,000.00
- Revenue This Year
- ROIV N/A
- BLD $0.36
- Revenue Next Year
- ROIV N/A
- BLD $3.55
- P/E Ratio
- ROIV N/A
- BLD $15.06
- Revenue Growth
- ROIV 140.04
- BLD 2.60
- 52 Week Low
- ROIV $9.96
- BLD $288.31
- 52 Week High
- ROIV $13.06
- BLD $495.68
- Technical
- Relative Strength Index (RSI)
- ROIV 42.16
- BLD 46.95
- Support Level
- ROIV $10.63
- BLD $295.60
- Resistance Level
- ROIV $11.42
- BLD $316.66
- Average True Range (ATR)
- ROIV 0.36
- BLD 8.51
- MACD
- ROIV -0.02
- BLD 1.89
- Stochastic Oscillator
- ROIV 7.59
- BLD 49.91
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About BLD TopBuild Corp.
TopBuild Corp is an installer and distributor of insulation products. Its operating segments involve the Installation and Specialty Distribution segment. The installation segment provides insulation installation services nationwide through contractor services business. Speciality Distribution segment distributes building and mechanical insulation, insulation accessories and other building product materials for the residential, commercial, and industrial end markets. The majority of revenue is earned from the installation segment. Its main customers are contractors. Other products include gutters, after-paint, garage doors, fireplaces, and fireproofing and stopping. TopBuild operates majorly in the United States.